Global Radial Head Resection Implants Market Trends and Insights
Rising Incidence of Irreparable and Comminuted Radial Head Fractures
Radial head fractures create a defined clinical base for the radial head resection implants market because comminuted injuries cannot always be reconstructed reliably. A 2025 registry study reported that concurrent elbow dislocation occurred in 25.9% of radial head fracture cases, increasing the need for procedures that restore joint stability. Complex injury patterns require surgeons to consider ligament integrity, forearm stability, and the risk of proximal radial migration rather than treating the fracture alone. This favors arthroplasty when fixation cannot preserve a stable and functional radiocapitellar relationship. The same injury burden supports demand across mature trauma systems and expanding orthopedic centers. It also places greater importance on product availability, surgical training, and implant options that can be selected during a time-sensitive trauma procedure.Increasing Use of Radial Head Arthroplasty in Complex Elbow Instability
Radial head arthroplasty is increasingly used when terrible triad injuries or Essex-Lopresti lesions require the radial head to contribute to forearm stability. A 2026 population-based cohort study of 3,159 surgical cases associated arthroplasty with a 10-year cumulative reoperation incidence of 10.4%, compared with 15.8% for open reduction and internal fixation. That clinical result reinforces the role of replacement in cases where fracture fixation is unlikely to provide durable stability. The radial head resection implants market benefits when clinical decision-making gives greater weight to long-term reoperation risk. Younger patients receiving arthroplasty for severe injuries may also require follow-up over a longer period, making revision planning relevant to the product lifecycle. The commercial opportunity therefore extends beyond primary trauma procedures to systems that support difficult revision surgery.Revision Risk From Loosening, Stiffness, and Capitellar Erosion
Revision risk remains a practical restraint because outcomes depend on stem selection, implant size, surgical technique, and patient anatomy. A 2026 meta-analysis covering 4,467 elbows reported revision rates of 3.4% for loose-fit stems and 8.0% for press-fit stems before adjustment for follow-up time. The same evidence found that the apparent survival advantage disappeared after accounting for follow-up duration, which cautions against simple design claims. Stiffness, pain, loosening, and cartilage wear can require further surgery, especially when sizing or alignment is not appropriate. This clinical sensitivity can limit use outside centers that perform elbow reconstruction regularly. It also supports demand for trial systems, education, and design features that help avoid overstuffing and unstable reconstruction.Other drivers and restraints analyzed in the detailed report include:
- Shift Toward Anatomical, Modular, and Alignment Technologies
- Demand for Cartilage-Preserving and Porous-Fixation Technologies
- Evidence, Surgeon Familiarity, Reimbursement, and Specialist Access Constraints
Segment Analysis
Modular implants held 52.3% of revenue in 2026, giving them the leading position in the radial head resection implants market share. Their separate head and stem components allow surgeons to refine fit, restore length, and respond to uncertainty in the fractured anatomy during surgery. This feature is relevant in comminuted fractures, where landmarks are disrupted and the original head may not be useful as a direct guide. Broad modular portfolios also help hospitals manage varied trauma presentations without changing the core surgical workflow or training pathway for each case. Acumed’s Anatomic Radial Head Solutions 2 offers 924 head-stem combinations, while Stryker’s Evolve Proline offers 324 combinations, demonstrating the value placed on extensive size and configuration choice.Monoblock implants are forecast to grow at an 8.5% CAGR through 2032. Their one-piece construction removes the modular junction and may reduce concerns about fretting or component dissociation during use. This design can also reduce the number of trays, instruments, and assembly steps needed for a procedure, which may be relevant in time-sensitive trauma care. A 2026 study of 19 patients using a DePuy Synthes monoblock loose-fit system reported a Mayo Elbow Performance Score of 90 and no revisions at a mean 14.9-month follow-up. The supplied clinical review also links loose-fit approaches with fewer concerns about rigid stem fixation in selected patients. In the radial head resection implants industry, monoblock systems appeal where lower instrumentation demands, accessible pricing, and direct workflow matter most.
Monopolar implants commanded 58.8% of revenue in 2026, making them the largest polarity category. Their established clinical history and simpler implantation approach support continued use in straightforward acute Mason type III fracture cases. The 2025 meta-analysis of 809 patients reported similar Mayo Elbow Performance Scores for monopolar and bipolar systems, at 86.7 and 87.4, respectively. It also reported statistically similar revision rates of 4.1% for monopolar devices and 6.6% for bipolar devices. These findings support the ongoing role of monopolar products when surgeons prefer a conventional fixed-axis reconstruction with familiar instrumentation, published clinical experience, predictable operating-room steps, and straightforward availability through established trauma purchasing channels in the radial head resection implants market.
Bipolar implants are forecast to grow at an 8.8% CAGR through 2032. Their articulation can accommodate forearm rotation in complex instability cases, including terrible triad injuries and Essex-Lopresti lesions. This functional distinction gives bipolar systems a place when injury severity makes rotational accommodation particularly important to the planned reconstruction. A 2025 study of 64 bipolar radial head arthroplasty patients reported a mean Oxford Elbow Score of 88 and high patient satisfaction. A separate 2025 long-term study of cemented bipolar Judet prostheses reported 90% patient satisfaction and a mean Mayo Elbow Performance Score of 89. The evidence helps explain why bipolar products are gaining consideration at centers treating complex elbow instability, where surgeons may prioritize rotational accommodation, stability assessment, and a construct suited to multi-structure injury patterns in the radial head resection implants market.
Complete Report Scope:
- By Product Architecture
- Modular Implants
- Standard Modular Implants
- Anatomical Modular Implants
- Revision Modular Implants
- Monoblock Implants
- Modular Implants
- By Implant Polarity
- Monopolar Implants
- Bipolar Implants
- By Material
- Cobalt-Chromium Alloys
- Titanium Alloys
- Stainless Steel
- Pyrocarbon
- Synthetic-Cartilage and Polymer-Based Materials
- By Implant Size
- Below 20 mm
- 20-25 mm
- Above 25 mm
- By Application
- Primary Radial Head Replacement
- Revision Radial Head Replacement
- Replacement After Radial Head Resection
- Replacement for Degenerative or Post-Traumatic Disability
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Orthopedic Clinics
- Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East and Africa
- GCC
- South Africa
- Rest of Middle East and Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Geography Analysis
North America held 42.6% of revenue in 2026, giving it the leading position in the radial head resection implants market share. The region combines high procedure volumes, dense orthopedic subspecialty coverage, and a mature payer environment. The United States remains the principal launch setting for new systems because its trauma and upper-extremity surgeons adopt specialized devices through established hospital and outpatient networks. Arthrex received FDA 510(k) clearance in July 2026 for its radial head replacement system, showing continued product development for the United States. Medartis acquired the Avenger Radial Head System in March 2025 and began immediate United States distribution, expanding its elbow trauma offering.Asia-Pacific is forecast to grow at a 7.5% CAGR through 2032, the highest rate among the reported regions. Growth is linked to expanding hospital capacity, rising traumatic injuries, and broader insurance coverage in China, India, and South Korea. India’s insurance expansion supports a larger potential payer base for surgical care, though the supplied source does not provide a radial-head-specific coverage measure. China’s procurement environment can place pressure on implant prices while increasing access to surgical treatment. The Radial Head Resection Implants Market will require pricing, training, and distribution models that reflect substantial differences across Asia-Pacific healthcare systems.
Europe remains an important procedural base, with Germany, the United Kingdom, and France supporting much of the region’s orthopedic activity. Europe’s regulatory influence comes from the Medical Device Regulation 2017/745, which requires conformity assessment and CE marking for eligible devices. Germany’s reimbursement structure can favor established systems when hospitals face bundled payments and limited recovery for high-value implants, as reported by BVASK in 2025. Middle East and Africa volumes remain concentrated in private hospital networks and expanding specialty centers, while South America offers a gradual opportunity as access to complex orthopedic care expands.
List of Companies Covered in this Report:
- Acumed
- Adler Ortho
- Arthrex
- Aston Medical
- Auxein Medical
- Beznoska
- BioPoly LLC
- ChM sp. z o.o.
- In2Bones Global, Inc.
- implantcast GmbH
- Integra LifeSciences
- Johnson & Johnson MedTech
- Medartis
- Siora Surgicals
- Skeletal Dynamics
- Smiths Group
- Stryker
- XLO Orthopaedic
- Zimmer Biomet
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
Table of Contents
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Acumed
- Adler Ortho
- Arthrex, Inc.
- Aston Medical
- Auxein Medical
- Beznoska
- BioPoly LLC
- ChM sp. z o.o.
- In2Bones Global, Inc.
- implantcast GmbH
- Integra LifeSciences
- Johnson & Johnson MedTech
- Medartis AG
- Siora Surgicals
- Skeletal Dynamics
- Smith & Nephew
- Stryker
- XLO Orthopaedic
- Zimmer Biomet

